Segmentectomy versus lobectomy. Which factors are decisive for an optimal oncological outcome?

• Published in: Kardiochirurgia i torakochirurgia polska Vol. 20; no. 3; pp. 179 - 186
• Main Authors: Galanis, Michail, Leivaditis, Vasileios, Gioutsos, Konstantinos, Panagiotopoulos, Ioannis, Kyratzopoulos, Asterios, Mulita, Francesk, Papaporfyriou, Anastasia, Verras, Georgios-Ioannis, Tasios, Konstantinos, Antzoulas, Andreas, Skevis, Konstantinos, Kontou, Theoni, Koletsis, Efstratios, Ehle, Benjamin, Dahm, Manfred, Grapatsas, Konstantinos
• Format: Journal Article
• Language: English
• Published: Termedia Publishing House 01.01.2023
• Subjects: disease-free survival; lobectomy; non-small-cell lung carcinoma; overall survival; recurrence; Review Paper; segmentectomy
• ISSN: 1731-5530; 1897-4252
• DOI: 10.5114/kitp.2023.131943

Low-dose computed tomography is being used for lung cancer screening in high-risk groups. Detecting lung cancer at an early stage improves the chance of optimal treatment and increases overall survival. This article compares segmentectomy vs. lobectomy as surgical options, in the case of stage I non-small cell lung carcinoma, ideally IA. To compare the 2 previously referred strategies, data were collected from articles (40 studies were reviewed), reviews, and systematic analyses in PubMed Central, as well as reviewing recent literature. Segmentectomy could be an equal alternative to lobectomy in early-stage NSCLC (tumour < 2 cm). It could be preferred for patients with a low cardiopulmonary reserve, who struggle to survive a lobectomy. As far as early-stage NSCLC is concerned, anatomic segmentectomy is an acceptable procedure in a selective group of patients. For better tumour and stage classification, a systematic lymph node dissection should be performed.